Aaron M. Mohs

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Michael Bouvet · 5 shared papers, 2023–2025 · strength 0.97
   • Paper Mucin4 (MUC4) Antibody Labeled with an NIR Dye Brightly Targets Pancreatic Cancer Liver Metastases and Peritoneal Carci… DOI 10.3390/cancers17122031↗
   • Paper Brightly Visualizing Pancreatic Cancer Margins in Orthotopic Mouse Models with an Anti-CA19-9 Antibody Conjugated to a … DOI 10.3390/cancers17162617↗
   • Paper Targeting Human Pancreatic Cancer with a Fluorophore-Conjugated Mucin 4 (MUC4) Antibody: Initial Characterization in Or… DOI 10.3390/jcm13206211↗
2. Surinder K. Batra · 5 shared papers, 2023–2025 · strength 0.97
   • Paper Mucin4 (MUC4) Antibody Labeled with an NIR Dye Brightly Targets Pancreatic Cancer Liver Metastases and Peritoneal Carci… DOI 10.3390/cancers17122031↗
   • Paper Brightly Visualizing Pancreatic Cancer Margins in Orthotopic Mouse Models with an Anti-CA19-9 Antibody Conjugated to a … DOI 10.3390/cancers17162617↗
   • Paper Targeting Human Pancreatic Cancer with a Fluorophore-Conjugated Mucin 4 (MUC4) Antibody: Initial Characterization in Or… DOI 10.3390/jcm13206211↗
3. Michael Anthony Hollingsworth · 6 shared papers, 2018–2025 · strength 0.90
   • Paper Humanized Anti-MUC16 Antibody-Conjugated Contrast Agents for Magnetic Resonance Imaging of Pancreatic Cancer. DOI 10.3390/cancers17060957↗
   • Paper Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer. DOI 10.1016/j.canlet.2023.216150↗
   • Paper Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expr… DOI 10.1021/acs.molpharmaceut.2c00203↗
4. Robert M. Hoffman · 4 shared papers, 2023–2025 · strength 0.78
   • Paper Mucin4 (MUC4) Antibody Labeled with an NIR Dye Brightly Targets Pancreatic Cancer Liver Metastases and Peritoneal Carci… DOI 10.3390/cancers17122031↗
   • Paper Brightly Visualizing Pancreatic Cancer Margins in Orthotopic Mouse Models with an Anti-CA19-9 Antibody Conjugated to a … DOI 10.3390/cancers17162617↗
   • Paper Targeting Human Pancreatic Cancer with a Fluorophore-Conjugated Mucin 4 (MUC4) Antibody: Initial Characterization in Or… DOI 10.3390/jcm13206211↗
5. Kavita B. Mallya · 4 shared papers, 2023–2025 · strength 0.78
   • Paper Mucin4 (MUC4) Antibody Labeled with an NIR Dye Brightly Targets Pancreatic Cancer Liver Metastases and Peritoneal Carci… DOI 10.3390/cancers17122031↗
   • Paper Brightly Visualizing Pancreatic Cancer Margins in Orthotopic Mouse Models with an Anti-CA19-9 Antibody Conjugated to a … DOI 10.3390/cancers17162617↗
   • Paper Targeting Human Pancreatic Cancer with a Fluorophore-Conjugated Mucin 4 (MUC4) Antibody: Initial Characterization in Or… DOI 10.3390/jcm13206211↗
6. Sunidhi Jaiswal · 3 shared papers, 2024–2025 · strength 0.62
   • Paper Mucin4 (MUC4) Antibody Labeled with an NIR Dye Brightly Targets Pancreatic Cancer Liver Metastases and Peritoneal Carci… DOI 10.3390/cancers17122031↗
   • Paper Brightly Visualizing Pancreatic Cancer Margins in Orthotopic Mouse Models with an Anti-CA19-9 Antibody Conjugated to a … DOI 10.3390/cancers17162617↗
   • Paper Targeting Human Pancreatic Cancer with a Fluorophore-Conjugated Mucin 4 (MUC4) Antibody: Initial Characterization in Or… DOI 10.3390/jcm13206211↗
7. Maneesh Jain · 3 shared papers, 2024–2025 · strength 0.62
   • Paper Mucin4 (MUC4) Antibody Labeled with an NIR Dye Brightly Targets Pancreatic Cancer Liver Metastases and Peritoneal Carci… DOI 10.3390/cancers17122031↗
   • Paper Brightly Visualizing Pancreatic Cancer Margins in Orthotopic Mouse Models with an Anti-CA19-9 Antibody Conjugated to a … DOI 10.3390/cancers17162617↗
   • Paper Targeting Human Pancreatic Cancer with a Fluorophore-Conjugated Mucin 4 (MUC4) Antibody: Initial Characterization in Or… DOI 10.3390/jcm13206211↗
8. Geoffrey A. Talmon · 4 shared papers, 2020–2024 · strength 0.61
   • Paper MUC16 Retention after Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16203439↗
   • Paper Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expr… DOI 10.1021/acs.molpharmaceut.2c00203↗
   • Paper Tuned near infrared fluorescent hyaluronic acid conjugates for delivery to pancreatic cancer for intraoperative imaging. DOI 10.7150/thno.40688↗
9. Kristin E. Cox · 3 shared papers, 2023–2025 · strength 0.55
   • Paper Brightly Visualizing Pancreatic Cancer Margins in Orthotopic Mouse Models with an Anti-CA19-9 Antibody Conjugated to a … DOI 10.3390/cancers17162617↗
   • Paper Targeting Human Pancreatic Cancer with a Fluorophore-Conjugated Mucin 4 (MUC4) Antibody: Initial Characterization in Or… DOI 10.3390/jcm13206211↗
   • Paper Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Mod… DOI 10.3390/jpm13050857↗
10. Kathryn M. Muilenburg · 3 shared papers, 2022–2024 · strength 0.55
    • Paper MUC16 Retention after Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16203439↗
    • Paper Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer. DOI 10.1016/j.canlet.2023.216150↗
    • Paper Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expr… DOI 10.1021/acs.molpharmaceut.2c00203↗
11. Mark A. Carlson · 3 shared papers, 2022–2024 · strength 0.55
    • Paper MUC16 Retention after Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16203439↗
    • Paper Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer. DOI 10.1016/j.canlet.2023.216150↗
    • Paper Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expr… DOI 10.1021/acs.molpharmaceut.2c00203↗
12. Prakash Radhakrishnan · 3 shared papers, 2020–2025 · strength 0.55
    • Paper Humanized Anti-MUC16 Antibody-Conjugated Contrast Agents for Magnetic Resonance Imaging of Pancreatic Cancer. DOI 10.3390/cancers17060957↗
    • Paper Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer. DOI 10.1016/j.canlet.2023.216150↗
    • Paper Development of a MUC16-Targeted Near-Infrared Fluorescent Antibody Conjugate for Intraoperative Imaging of Pancreatic C… DOI 10.1158/1535-7163.mct-20-0033↗
13. Madeline T. Olson · 3 shared papers, 2020–2024 · strength 0.49
    • Paper MUC16 Retention after Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16203439↗
    • Paper Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expr… DOI 10.1021/acs.molpharmaceut.2c00203↗
    • Paper Development of a MUC16-Targeted Near-Infrared Fluorescent Antibody Conjugate for Intraoperative Imaging of Pancreatic C… DOI 10.1158/1535-7163.mct-20-0033↗
14. Thinzar Min Lwin · 2 shared papers, 2024–2025 · strength 0.39
    • Paper Brightly Visualizing Pancreatic Cancer Margins in Orthotopic Mouse Models with an Anti-CA19-9 Antibody Conjugated to a … DOI 10.3390/cancers17162617↗
    • Paper Targeting Human Pancreatic Cancer with a Fluorophore-Conjugated Mucin 4 (MUC4) Antibody: Initial Characterization in Or… DOI 10.3390/jcm13206211↗
15. Thomas C. Caffrey · 2 shared papers, 2020–2025 · strength 0.36
    • Paper Humanized Anti-MUC16 Antibody-Conjugated Contrast Agents for Magnetic Resonance Imaging of Pancreatic Cancer. DOI 10.3390/cancers17060957↗
    • Paper Development of a MUC16-Targeted Near-Infrared Fluorescent Antibody Conjugate for Intraoperative Imaging of Pancreatic C… DOI 10.1158/1535-7163.mct-20-0033↗
16. Christabelle Rajesh · 1 shared paper, 2025 · strength 0.25
    • Paper Humanized Anti-MUC16 Antibody-Conjugated Contrast Agents for Magnetic Resonance Imaging of Pancreatic Cancer. DOI 10.3390/cancers17060957↗
17. Jayasindu Mathiyazhagan · 1 shared paper, 2025 · strength 0.25
    • Paper Humanized Anti-MUC16 Antibody-Conjugated Contrast Agents for Magnetic Resonance Imaging of Pancreatic Cancer. DOI 10.3390/cancers17060957↗
18. Satish Sagar · 1 shared paper, 2025 · strength 0.25
    • Paper Humanized Anti-MUC16 Antibody-Conjugated Contrast Agents for Magnetic Resonance Imaging of Pancreatic Cancer. DOI 10.3390/cancers17060957↗
19. Bowen Qi · 2 shared papers, 2018–2020 · strength 0.20
    • Paper Tuned near infrared fluorescent hyaluronic acid conjugates for delivery to pancreatic cancer for intraoperative imaging. DOI 10.7150/thno.40688↗
    • Paper Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic canc… DOI 10.1016/j.nano.2017.12.015↗
20. Michael A. Turner · 1 shared paper, 2023 · strength 0.16
    • Paper Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Mod… DOI 10.3390/jpm13050857↗
21. Hiroto Nishino · 1 shared paper, 2023 · strength 0.16
    • Paper Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Mod… DOI 10.3390/jpm13050857↗
22. Eric N. Aguilar · 1 shared paper, 2022 · strength 0.15
    • Paper Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expr… DOI 10.1021/acs.molpharmaceut.2c00203↗
23. Joshua J. Souchek · 1 shared paper, 2018 · strength 0.08
    • Paper Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic canc… DOI 10.1016/j.nano.2017.12.015↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.